Literature DB >> 12073741

Assessing and enhancing adherence to medical regimens for juvenile rheumatoid arthritis.

Michael A Rapoff1.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12073741     DOI： 10.3928/0090-4481-20020601-09

Source DB:  PubMed          Journal:  Pediatr Ann        ISSN： 0090-4481            Impact factor:   1.132


× No keyword cloud information.
  6 in total

1.  Adherence to treatment in adolescents.

Authors:  Danielle Taddeo; Maud Egedy; Jean-Yves Frappier
Journal:  Paediatr Child Health       Date:  2008-01       Impact factor: 2.253

Review 2.  Importance of adherence in the outcome of juvenile idiopathic arthritis.

Authors:  Claudio A Len; Vanessa B Miotto e Silva; Maria Teresa R A Terreri
Journal:  Curr Rheumatol Rep       Date:  2014-04       Impact factor: 4.592

3.  Practice-Based Approach to Assessing and Treating Non-Adherence in Pediatric Regimens.

Authors:  Christina L Duncan; Janelle M Mentrikoski; Yelena P Wu; Emily M Fredericks
Journal:  Clin Pract Pediatr Psychol       Date:  2014-09

4.  Adherence to methotrexate in juvenile idiopathic arthritis.

Authors:  Christina F Pelajo; Caitlin M Sgarlat; Jorge M Lopez-Benitez; Sheila K F Oliveira; Marta C F Rodrigues; Flavio R Sztajnbok; Christianne C Diniz; Laurie C Miller
Journal:  Rheumatol Int       Date:  2011-01-19       Impact factor: 2.631

5.  Usability testing of an online self-management program for adolescents with juvenile idiopathic arthritis.

Authors:  Jennifer Stinson; Patrick McGrath; Ellen Hodnett; Brian Feldman; Ciaran Duffy; Adam Huber; Lori Tucker; Ross Hetherington; Shirley Tse; Lynn Spiegel; Sarah Campillo; Navreet Gill; Meghan White
Journal:  J Med Internet Res       Date:  2010-07-29       Impact factor: 5.428

6.  Adherence to Methotrexate therapy in Rheumatoid Arthritis.

Authors:  Nasim Arshad; Nighat Mir Ahmad; Muhammad Ahmed Saeed; Saira Khan; Shabnam Batool; Sumaira Farman
Journal:  Pak J Med Sci       Date:  2016 Mar-Apr       Impact factor: 1.088
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.